Vioxx was a COX-2 inhibitor that was recalled by Merck Frosst in October of 2004. Cuming Gillespie & Raymaker is part of a consortium of Canadian lawyers that is actively pursuing an Alberta and Canada wide class action on behalf of individuals who have taken Vioxx and suffered injury.
May 2nd, 2008 - Vioxx Update
The national certification hearing on Vioxx is now set for June 24-27 in Toronto, Canada.
March 5th, 2008 - Vioxx Update
January 23rd, 2008 - Vioxx Update
Cuming, Gillespie & Raymaker continue to proceed with the Canadian National Class Action with respect to the Vioxx claims.
The Vioxx claims within the U.S. only have been resolved for the sum of $4,850,000.00 dollars pursuant to an agreement between Merck & Co. Inc and a six member negotiating committee on behalf of all U.S. Plaintiffs. The details of the U.S. settlement are available online at www.officialvioxxsettlement.com.
The claim has not resolved and will be proceeding to a certification hearing in 2008.